Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Chromogranin A (344-364) fragment

Known as: catestatin, chromogranin A (344-364) 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Catestatin, a catecholamine-release inhibitory peptide, has multiple cardiovascular activities. Conflicting results have been… Expand
2012
2012
New endogenous antimicrobial peptides (AMPs) derived from chromogranin A (CgA) are secreted by nervous, endocrine and immune… Expand
2010
2010
BACKGROUND Obstructive sleep apnea (OSA) is common in children and leads to multiple end-organ morbidities induced by the… Expand
2010
2010
Catestatin is a natural peptide of higher organisms including humans, with a wide variety of biological functions involved in… Expand
Highly Cited
2009
Highly Cited
2009
We reported previously that chromogranin A (Chga) knockout (KO) mice are hypertensive and hyperadrenergic. Here we sought to… Expand
2004
2004
Previous modeling (PDB 1cfk) of the catecholamine release-inhibitory "catestatin" region of chromogranin A (CgA) suggested a beta… Expand
Highly Cited
2002
Highly Cited
2002
The catestatin fragment of chromogranin A is the first known endogenous compound able to inhibit catecholamine release elicited… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2000
Highly Cited
2000
The novel chromogranin A fragment catestatin (bovine chromogranin A(344-364); RSMRLSFRARGYGFRGPGLQL) is a potent inhibitor of… Expand
2000
2000
The catecholamine release-inhibitory chromogranin A fragment catestatin (chromogranin A(344-364)) exhibits non-competitive… Expand
1998
1998
Publisher Summary Proteolysis of chromogranin A takes place both within secretory granules and extracellularly, giving rise to… Expand